Table 1.
Thresholds (μA) | Latencies (s) | |||
---|---|---|---|---|
Saline | Nicotine | Saline | Nicotine | |
Exp. 1A R278995/CRA0450-CeA (saline, n = 9; nicotine, n = 8) | ||||
Prior pump implantation | 123.3 ± 14.5 | 119.0 ± 13.2 | 3.1 ± 0.1 | 3.0 ± 0.2 |
Prior first injection | 113.8 ± 15.3 | 108.8 ± 13.4 | 3.2 ± 0.2 | 3.0 ± 0.2 |
Exp. 1B R278995/CRA0450-BLA (nicotine, n = 6) | ||||
Prior pump implantation | N/A | 85.8 ± 9.3 | N/A | 3.5 ± 0.1 |
Prior first injection | N/A | 82.7 ± 11.3 | N/A | 2.9 ± 0.1 |
Exp. 2 Prazosin-CeA (saline, n = 10; nicotine, n = 10) | ||||
Prior pump implantation | 96.3 ± 7.1 | 88.8 ± 8.5 | 3.3 ± 0.1 | 3.3 ± 0.1 |
Prior first injection | 100.2 ± 6.6 | 94.4 ± 8.9 | 3.5 ± 0.1 | 3.4 ± 0.1 |
Exp. 3 Clonidine-CeA (saline, n = 8; nicotine, n = 13) | ||||
Prior pump implantation | 100.7 ± 7.7 | 112.5 ± 10.6 | 3.1 ± 0.1 | 3.6 ± 0.2* |
Prior first injection | 101.1 ± 8.1 | 115.7 ± 11.4 | 3.2 ± 0.1 | 3.5 ± 0.2 |
Prior refers to the test-day immediately before the implantation of the osomotic minipumps or the start of the mecamylamine injections. Asterisk (P<0.05) indicates that the latency of the nicotine group is longer than the latency of the saline group. Abbreviations: CeA, central nucleus of the amygdala; BLA, basolateral nucleus of the amygdala.